NMR Spectroscopy for Peptides: What It Shows and When It Is Used

In plain English

Some atomic nuclei behave like tiny magnets. Hydrogen is the most useful one for peptides (short chains of amino acids). In a strong magnetic field, these nuclei sit in a few allowed orientations, called spin states ^[1]. A pulse of radio waves moves them between states, and as they settle back they give off a faint radio signal.

The exact frequency of that signal depends on the atoms around each nucleus. NMR reports it as a chemical shift (a position on a scale measured in parts per million, or ppm) ^[1]. A hydrogen on the peptide backbone appears in a different place from a hydrogen on a side chain, so the spectrum becomes a map of the molecule ^[3].

NMR can show that each expected amino acid is present, which hydrogens are near each other, how much peptide is in a weighed sample, and whether the salt trifluoroacetate (TFA) is present ^{[3, 12, 14]}. Its main drawback is low sensitivity: it needs far more material than most analytical methods ^[2].

The short version

• NMR reads the chemical surroundings of individual atoms.
• Two-dimensional (2D) experiments link signals residue by residue.
• Short peptides are flexible, so NMR often sees an average of many shapes.
• qNMR measures peptide content; ¹⁹F NMR measures TFA.

How NMR works: spin states and chemical shift

Nuclei with a property called spin, such as ¹H, ¹³C, ¹⁵N and ¹⁹F, take up distinct spin states in a magnetic field. Radiofrequency pulses move nuclei between those states, and the instrument records the signal as they return ^[1]. Electrons around each nucleus partly shield it from the field, so chemically different nuclei resonate at slightly different frequencies.

IUPAC defines the chemical shift (δ) relative to a reference signal, conventionally the ¹H signal of tetramethylsilane (TMS), with separate practice for aqueous biochemical samples ^[1]; peptide work in water often adds the water-soluble reference TSP ^[3]. Because δ is a ratio, expressed in ppm, it does not depend on the strength of the magnet.

Worked example: from hertz to ppm

On a 600 MHz spectrometer, 1 ppm corresponds to 600 Hz. A signal 4,920 Hz above the reference sits at 4,920 ÷ 600 = 8.20 ppm, in the amide region of a peptide spectrum ^[3]. On a 400 MHz instrument the same proton is still at 8.20 ppm, but only 3,280 Hz (8.20 × 400) from the reference. Reporting ppm lets spectra from different instruments be compared directly.

The nuclei used for peptides

Because ¹³C and ¹⁵N are rare in material that has not been isotope-enriched, their signals are weak. Even so, standards and regulatory laboratories have used 2D ¹H–¹⁵N spectra at natural abundance to fingerprint the folded structure of a recombinant protein medicine ^[15].

Reading a 1D ¹H spectrum of a peptide

Each chemically distinct proton gives a signal, and the area of a signal is proportional to the number of nuclei producing it ^[2]. A teaching data set of simple peptide spectra divides the ¹H spectrum into four main regions ^[3]:

Three practical points follow.

1. Solvent. Amide hydrogens exchange with hydrogens of the solvent ^[6]. In 100% D₂O (heavy water), amide N–H becomes N–D and the amide signals disappear, so peptide spectra are usually recorded in 90% H₂O/10% D₂O with water suppression ^[3]. Other studies use deuterated organic solvents such as DMSO-d₆ ^[9].
2. Reference values. Chemical shifts of all 20 common amino acids in an unstructured (“random coil”) peptide have been measured under identical aqueous conditions ^[4]. Departures from these values point to structure.
3. Secondary structure. The Hα shift moves upfield (to lower ppm) in a helix and downfield in an extended β-strand compared with the random-coil value. The chemical shift index uses this pattern to locate helices and strands from assigned spectra ^[5].

The HN–Hα coupling (³J_αN) adds further information: about 7 Hz indicates random coil, below about 6 Hz suggests helical backbone angles, and above about 8 Hz suggests extended, β-like angles ^[3].

2D NMR and sequential assignment

Even for simple peptides, signals usually cannot be assigned from a 1D spectrum alone ^[3]. Two-dimensional experiments spread signals over two frequency axes, and each off-diagonal cross-peak shows that two nuclei are connected.

The sequential “walk”

Kurt Wüthrich shared the 2002 Nobel Prize in Chemistry for developing NMR methods to determine the three-dimensional structure of biological macromolecules in solution ^[8]. A central step is sequential assignment, an approach described in 1981 using combined COSY and NOESY data ^[7]:

1. Find each residue’s spin system in the TOCSY spectrum. A valine, a leucine and a serine each give a characteristic pattern of HN, Hα, Hβ and further side-chain cross-peaks ^[3].
2. Link neighbours in the NOESY spectrum. The Hα of one residue lies close in space to the HN of the next residue, so a NOE cross-peak joins them. Following Hα(i) → HN(i+1) → Hα(i+1) → HN(i+2) “walks” along the chain ^[3].
3. Match the walk to the known sequence. Proline has no amide hydrogen, so it breaks the HN chain of links, although its Hα still correlates with the HN of the following residue ^[3].
4. Resolve overlap with ¹H–¹³C and ¹H–¹⁵N HSQC spectra where proton signals coincide, as in the full assignment of the seven-residue peptide angiotensin-(1–7) at 400 and 600 MHz ^[10].

A complete assignment confirms the sequence independently of mass spectrometry, which mainly measures mass. See Reading a Peptide Mass Spectrum.

NOE distances and why short peptides look “averaged”

NOE intensity falls steeply with distance, scaling with the inverse sixth power of the separation between two protons (r⁻⁶). Structure calculations turn observed NOEs into upper-bound distance restraints, the key ingredient of NMR structure determination ^[11].

Short linear peptides behave differently. Two-dimensional NMR studies detected folded structures in short peptide fragments of proteins in water, but these structures were in rapid exchange with unfolded states ^[13]. NMR parameters such as the ³J_αN coupling then report a population-weighted average over all the shapes present ^[3].

This averaging has consequences that matter when reading a published peptide structure:

• Averages can mislead. Because of r⁻⁶ averaging, a minority of compact shapes can dominate the NOEs. In one analysis, simulated ensembles of highly non-native structures still matched experimental NOE upper bounds fairly well ^[11].
• One structure may not fit. For a nine-residue peptide, single conformations or a limited set of structures were insufficient to describe the measured cross-relaxation (NOESY/ROESY) data ^[16].
• Methods can seem to disagree. For two closely related β-peptides in methanol, circular dichroism suggested more helix in one, while NMR showed slightly more NOEs for the other. Molecular dynamics showed both results could arise from a single ensemble ^[17]. See Circular Dichroism (CD).

A peptide “NMR structure” drawn as one tidy shape is therefore often a model of the most populated conformations. For backbone geometry, see Peptide Bonds and Structure.

Quantitative NMR (qNMR) for peptide content

NMR is a primary ratio method: signal area is directly proportional to the number of nuclei, and the response does not depend on molecular structure the way UV absorbance does ^{[2, 12]}. That allows content to be measured directly against an internal calibrant of known purity, without a reference standard of the peptide itself ^{[12, 18, 20]}. Quantitative ¹H NMR can also reveal components that escape chromatographic detection, such as water and residual solvents ^{[12, 18]}.

The calculation compares the integral of a peptide signal with that of the calibrant, corrected for the number of protons in each signal (N), molar mass (M) and weighed mass (m) ^[18]:

Content (mass fraction) = (I_peptide ÷ I_cal) × (N_cal ÷ N_peptide) × (M_peptide ÷ M_cal) × (m_cal ÷ m_sample) × P_cal

Worked example

A 10.00 mg sample of angiotensin II (molar mass 1,046.2 g/mol ^[19]) is dissolved with 2.00 mg of a certified calibrant (molar mass 116.07 g/mol, purity 99.9%). A two-proton peptide signal and a two-proton calibrant signal are integrated, giving a ratio I_peptide ÷ I_cal of 0.415.

• Mass ratio term: 1,046.2 ÷ 116.07 = 9.014
• Content = 0.415 × (2 ÷ 2) × 9.014 × (2.00 ÷ 10.00) × 0.999 = 0.747, or 74.7% peptide by mass

In this example the remaining 25% or so of the powder would be water, counter-ions and other non-peptide material, which is why purity and content are separate results. See Purity vs Peptide Content and Amino Acid Analysis.

A US Pharmacopeia-led collaborative study, with national laboratories including the TGA, compared HPLC assay, qNMR and amino acid analysis for a nine-residue peptide. HPLC assay showed the lowest between-laboratory variability; the authors concluded that qNMR, being simpler and faster, deserves further exploration for assigning values to peptide reference standards ^[20]. The European Medicines Agency’s guideline on synthetic peptides lists qNMR among example methods for assay or content, alongside liquid chromatography, amino acid analysis and nitrogen analysis ^[21]. See Reference Standards Explained.

¹⁹F NMR for trifluoroacetate

Trifluoroacetic acid is used to cleave peptides from the synthesis resin and as an ion-pairing reagent in purification, so many synthetic peptides are obtained as TFA salts ^[14]. Natural amino acids contain no fluorine, so the TFA signal stands alone in a ¹⁹F spectrum.

A 2025 study validated a ¹⁹F NMR method for residual TFA according to ICH guidelines. Samples of 2 mg/mL peptide salt were measured in 10% D₂O on a 400 MHz instrument. The method showed bias below 10% and precision better than 3%, with a limit of quantification of 10.3 µg TFA per mg of peptide salt ^[14]. In the same study, one purified peptide contained 0.333 mg TFA per mg of peptide salt before counter-ion exchange, and the peptides tested held more TFA than their positive charges alone would predict ^[14]. The EMA guideline lists residual TFA as a specification test for synthetic peptides ^[21]. See Peptide Counter-Ions: TFA and Acetate.

Practical requirements and limits

What this means in Australia

• Testing laboratories. NATA accredits Australian testing laboratories to ISO/IEC 17025, the international standard for testing competence. Accreditation is a useful signal when judging who produced an NMR report ^[22].
• The TGA has worked on peptide qNMR. TGA laboratory staff were among the participants in the USP-led collaborative study that compared qNMR with HPLC assay and amino acid analysis for peptide quantification ^[20].
• Labels do not change status. The TGA has stated that a “research use only” disclaimer does not make supply lawful, change regulatory status, permit importation, or remove advertising or supply obligations ^[23].
• Identity is not legality. An NMR spectrum confirms what a material is. It does not change its regulatory position: several peptides are named in Schedule 4 (prescription only) and Appendix D, clause 5 (possession without authority is illegal) of the current Poisons Standard (October 2026) ^[24].

This is general information, not legal advice. Laws change; check the current Poisons Standard and TGA guidance.

Frequently asked questions

What does NMR show about a peptide that mass spectrometry does not?

NMR shows how atoms are connected and which hydrogens are close in space, so a full assignment confirms sequence order and local structure ^{[3, 7]}. Mass spectrometry mainly reports mass, so the two methods are complementary.

What is a sequential assignment?

It is the process of naming every NMR signal. TOCSY identifies each residue’s pattern, and NOESY links the Hα of one residue to the amide HN of the next, walking along the chain ^{[3, 7]}.

Can NMR measure how much peptide is in a vial?

Yes. Quantitative ¹H NMR compares a peptide signal with an internal calibrant of known purity and gives content by mass ^{[12, 18]}. A multi-laboratory study found it simple to perform, although HPLC assay showed lower between-laboratory variability in that study ^[20].

How is TFA measured by NMR?

Peptides normally contain no fluorine, so ¹⁹F NMR shows a single TFA signal that can be quantified against calibrators. One validated method quantified down to about 10 µg TFA per mg of peptide salt ^[14].

Why can NMR results for short peptides be hard to interpret?

Short peptides switch rapidly between many shapes, so the measured values are averages over all of them. Because NOEs favour compact shapes, a single drawn structure can overstate how ordered the peptide is ^{[11, 13]}.

References

1. Harris RK, Becker ED, Cabral de Menezes SM, Goodfellow R, Granger P. NMR nomenclature: nuclear spin properties and conventions for chemical shifts. IUPAC recommendations 2001. Solid State Nucl Magn Reson. 2002;22(4):458–483. doi:10.1006/snmr.2002.0063. PMID: 12637147
2. Malet-Martino M, Holzgrabe U. NMR techniques in biomedical and pharmaceutical analysis. J Pharm Biomed Anal. 2011;55(1):1–15. doi:10.1016/j.jpba.2010.12.023. PMID: 21237608
3. Daniecki NJ, Costantini NV, Sametz GM, Zondlo NJ. A data set of simple 1-D and 2-D NMR spectra of peptides, including all encoded amino acids, for introductory instruction in protein biomolecular NMR spectroscopy. Biochemistry. 2026;65(7):918–935. doi:10.1021/acs.biochem.5c00514. PMID: 41812158
4. Wishart DS, Bigam CG, Holm A, Hodges RS, Sykes BD. ¹H, ¹³C and ¹⁵N random coil NMR chemical shifts of the common amino acids. I. Investigations of nearest-neighbor effects. J Biomol NMR. 1995;5(1):67–81. doi:10.1007/BF00227471. PMID: 7881273
5. Wishart DS, Sykes BD, Richards FM. The chemical shift index: a fast and simple method for the assignment of protein secondary structure through NMR spectroscopy. Biochemistry. 1992;31(6):1647–1651. doi:10.1021/bi00121a010. PMID: 1737021
6. Bai Y, Milne JS, Mayne L, Englander SW. Primary structure effects on peptide group hydrogen exchange. Proteins. 1993;17(1):75–86. doi:10.1002/prot.340170110. PMID: 8234246
7. Wagner G, Kumar A, Wüthrich K. Systematic application of two-dimensional ¹H nuclear-magnetic-resonance techniques for studies of proteins. 2. Combined use of correlated spectroscopy and nuclear Overhauser spectroscopy for sequential assignments of backbone resonances and elucidation of polypeptide secondary structures. Eur J Biochem. 1981;114(2):375–384. doi:10.1111/j.1432-1033.1981.tb05157.x. PMID: 6163631
8. Nobel Prize Outreach. The Nobel Prize in Chemistry 2002: summary. nobelprize.org. Accessed 25 October 2026.
9. Matsoukas JM, Bigam G, Zhou N, Moore GJ. ¹H-NMR studies of [Sar1]angiotensin II conformation by nuclear Overhauser effect spectroscopy in the rotating frame (ROESY): clustering of the aromatic rings in dimethylsulfoxide. Peptides. 1990;11(2):359–366. doi:10.1016/0196-9781(90)90093-k. PMID: 2356159
10. Lula I, Denadai AL, Resende JM, et al. Study of angiotensin-(1-7) vasoactive peptide and its beta-cyclodextrin inclusion complexes: complete sequence-specific NMR assignments and structural studies. Peptides. 2007;28(11):2199–2210. doi:10.1016/j.peptides.2007.08.011. PMID: 17904691
11. Zagrovic B, van Gunsteren WF. Comparing atomistic simulation data with the NMR experiment: how much can NOEs actually tell us? Proteins. 2006;63(1):210–218. doi:10.1002/prot.20872. PMID: 16425239
12. Holzgrabe U, Deubner R, Schollmayer C, Waibel B. Quantitative NMR spectroscopy—applications in drug analysis. J Pharm Biomed Anal. 2005;38(5):806–812. doi:10.1016/j.jpba.2005.01.050. PMID: 15893899
13. Wright PE, Dyson HJ, Lerner RA. Conformation of peptide fragments of proteins in aqueous solution: implications for initiation of protein folding. Biochemistry. 1988;27(19):7167–7175. doi:10.1021/bi00419a001. PMID: 3061450
14. Erckes V, Streuli A, Chamera Rendueles L, Krämer SD, Steuer C. Towards a consensus for the analysis and exchange of TFA as a counterion in synthetic peptides and its influence on membrane permeation. Pharmaceuticals (Basel). 2025;18(8):1163. doi:10.3390/ph18081163. PMID: 40872554
15. Brinson RG, Ghasriani H, Hodgson DJ, et al. Application of 2D-NMR with room temperature NMR probes for the assessment of the higher order structure of filgrastim. J Pharm Biomed Anal. 2017;141:229–233. doi:10.1016/j.jpba.2017.03.063. PMID: 28454057
16. Feenstra KA, Peter C, Scheek RM, van Gunsteren WF, Mark AE. A comparison of methods for calculating NMR cross-relaxation rates (NOESY and ROESY intensities) in small peptides. J Biomol NMR. 2002;23(3):181–194. doi:10.1023/a:1019854626147. PMID: 12238590
17. Niggli DA, Ebert MO, Lin Z, Seebach D, van Gunsteren WF. Helical content of a β(3)-octapeptide in methanol: molecular dynamics simulations explain a seeming discrepancy between conclusions derived from CD and NMR data. Chemistry. 2012;18(2):586–593. doi:10.1002/chem.201102667. PMID: 22162155
18. Pauli GF, Chen SN, Simmler C, et al. Importance of purity evaluation and the potential of quantitative ¹H NMR as a purity assay. J Med Chem. 2014;57(22):9220–9231. doi:10.1021/jm500734a. PMID: 25295852
19. National Center for Biotechnology Information. PubChem Compound Summary for CID 172198, Angiotensin II. pubchem.ncbi.nlm.nih.gov. Accessed 25 October 2026.
20. Li C, Bhavaraju S, Thibeault MP, et al. Survey of peptide quantification methods and comparison of their reproducibility: a case study using oxytocin. J Pharm Biomed Anal. 2019;166:105–112. doi:10.1016/j.jpba.2018.12.028. PMID: 30640042
21. European Medicines Agency. Guideline on the development and manufacture of synthetic peptides. EMA/CHMP/CVMP/QWP/367182/2025. Adopted 4 December 2025; effective 1 June 2026. ema.europa.eu. Accessed 25 October 2026.
22. National Association of Testing Authorities, Australia (NATA). Laboratory accreditation: ISO/IEC 17025. nata.com.au. Accessed 25 October 2026.
23. Therapeutic Goods Administration. Understanding your responsibilities when importing, compounding and supplying unapproved peptide products. Safety advisory, 13 April 2026. tga.gov.au. Accessed 25 October 2026.
24. Therapeutic Goods (Poisons Standard—October 2026) Instrument 2026 (F2026L01327). Federal Register of Legislation. legislation.gov.au. Accessed 25 October 2026.